Latest Navigenics Stories
In an era of commercialized medicine, direct-to-consumer (DTC) genetic testing has been on a steady rise.
23andMe, a company focused on personal genetics, recently took the first step in working towards Food and Drug Administration (FDA) clearance; the FDA plans to review the paperwork over the next few months.
Recently, genetic tests have been on the rise and are offered by more and more commercial producers. While there are many opportunities for people to participate in genetic testing, this doesn’t necessarily mean that people are following up on those services.
Researchers at Loyola University Chicago’s Stritch School of Medicine have found that patients see both benefits and risks from direct-to-consumer genetic tests.